D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

Abstract Background Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have been reported since December 2019. We aim to explore risk factors associated with mortality in COVID-19 patients and assess the use of D-dimer as a biomarker for disease severity and clinical outcome. Methods We retro...

Full description

Bibliographic Details
Main Authors: Yumeng Yao, Jiatian Cao, Qingqing Wang, Qingfeng Shi, Kai Liu, Zhe Luo, Xiang Chen, Sisi Chen, Kaihuan Yu, Zheyong Huang, Bijie Hu
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Journal of Intensive Care
Subjects:
D-dimer
Coronavirus disease-19
Biomarker
Severity
Mortality
Online Access:http://link.springer.com/article/10.1186/s40560-020-00466-z

Internet

http://link.springer.com/article/10.1186/s40560-020-00466-z

Similar Items